The effect of early versus delayed challenge after vaccination in controlling SHIV 89.6P infection.

[1]  D. Montefiori,et al.  Replicating adenovirus HIV/SIV recombinant priming alone or in combination with a gp140 protein boost results in significant control of viremia following a SHIV89.6P challenge in Mamu-A*01 negative rhesus macaques. , 2008, Virology.

[2]  L. Thomsen,et al.  Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combination. , 2008, The Journal of general virology.

[3]  A. Borsetti,et al.  Tat protein vaccination of cynomolgus macaques influences SHIV-89.6Pcy243 epitope variability , 2008, Virus Genes.

[4]  H. Robinson,et al.  Expansion and Exhaustion of T-Cell Responses during Mutational Escape from Long-Term Viral Control in Two DNA/Modified Vaccinia Virus Ankara-Vaccinated and Simian-Human Immunodeficiency Virus SHIV-89.6P-Challenged Macaques , 2008, Journal of Virology.

[5]  Anthony S Fauci,et al.  An HIV vaccine--evolving concepts. , 2007, The New England journal of medicine.

[6]  Lei Zhang,et al.  Understanding the mechanisms and limitations of immune control of HIV , 2007, Immunological reviews.

[7]  A. Perelson,et al.  Influence of Peak Viral Load on the Extent of CD4+ T-Cell Depletion in Simian HIV Infection , 2006, Journal of acquired immune deficiency syndromes.

[8]  David E. Anderson,et al.  Timing of retroviral infection influences anamnestic immune response in vaccinated primates. , 2005, Viral immunology.

[9]  D. Watkins,et al.  Attenuation of Simian Immunodeficiency Virus SIVmac239 Infection by Prophylactic Immunization with DNA and Recombinant Adenoviral Vaccine Vectors Expressing Gag , 2005, Journal of Virology.

[10]  A. Perelson,et al.  High-Potency Human Immunodeficiency Virus Vaccination Leads to Delayed and Reduced CD8+ T-Cell Expansion but Improved Virus Control , 2005, Journal of Virology.

[11]  D. Watkins,et al.  CD8+ T-Lymphocyte Response to Major Immunodominant Epitopes after Vaginal Exposure to Simian Immunodeficiency Virus: Too Late and Too Little , 2005, Journal of Virology.

[12]  D. Montefiori,et al.  Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques. , 2005, Virology.

[13]  Alan S. Perelson,et al.  Kinetics of Virus-Specific CD8+ T Cells and the Control of Human Immunodeficiency Virus Infection , 2004, Journal of Virology.

[14]  Alan S. Perelson,et al.  Different Dynamics of CD4+ and CD8+ T Cell Responses During and After Acute Lymphocytic Choriomeningitis Virus Infection 1 , 2003, The Journal of Immunology.

[15]  S. Rowland-Jones,et al.  The assessment of antigen-specific CD8+ T cells through the combination of MHC class I tetramer and intracellular staining. , 2002, Journal of immunological methods.

[16]  John P. Moore,et al.  AIDS vaccine models: Challenging challenge viruses , 2002, Nature Medicine.

[17]  Henryk Mach,et al.  Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity , 2002, Nature.

[18]  H. Günthard,et al.  Direct ex vivo analysis reveals distinct phenotypic patterns of HIV‐specific CD8+ T lymphocyte activation in response to therapeutic manipulation of virus load , 2001, European journal of immunology.

[19]  S. Rowland-Jones,et al.  Skewed maturation of memory HIV-specific CD8 T lymphocytes , 2001, Nature.

[20]  D. Bates,et al.  Mixed-Effects Models in S and S-PLUS , 2001 .

[21]  S. Moretti,et al.  Viral outcome of simian–human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys , 2007, Archives of Virology.

[22]  Sidaction.  Expanding access to HIV treatment through community-based organizations : a joint publication of Sidaction, the Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO) , 2005 .